CLASS II ONGOING Device recall · Reported 22 Jul 2026 · FDA Enforcement Report

The Vasoview Hemopro 2 Endoscopic Vessel Harvesting System recalled

Maquet Cardiovascular is recalling The Vasoview Hemopro 2 Endoscopic Vessel Harvesting System (, distributed nationwide in the US. The recall was initiated on 2 Jun 2026 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI 00607567700406, Serial/Lot Number 3000547797
Quantity recalled205 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2741-2026
FDA event ID
99259
Recalling firm
Maquet Cardiovascular, Wayne, NJ
Classification
Class II
Status
Ongoing
Recall initiated
2 Jun 2026
FDA classified
15 Jul 2026
Reported
22 Jul 2026
Type
Voluntary: Firm initiated
Customers notified by
Telephone
Reason category
Sterility

Timeline

2 Jun 2026Recall initiated by company
15 Jul 2026Classified by FDA+43 days
22 Jul 2026Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Getinge identified that Vasoview Hemopro 2 devices from Lot 3000547797 were exposed to an out-of-specification sterilization dose during a gamma sterilization run (Run ID 1183-28782A) performed by STERIS at its Whippany, NJ facility between March 31 and April 1 of 2026.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

The Vasoview Hemopro 2 Endoscopic Vessel Harvesting System (Model VH-4000; UDI 00607567700406) is a sterile, single-use Class II device that was cleared for marketing by FDA under 510(k) number K101274.

Where it was distributed

US Nationwide distribution in the states of NY, CA, SC, FL, TX, GA, OR.

Nationwide CaliforniaFloridaGeorgiaNew YorkOregonSouth CarolinaTexas

Questions about this recall

Why was it recalled?

Getinge identified that Vasoview Hemopro 2 devices from Lot 3000547797 were exposed to an out-of-specification sterilization dose during a gamma sterilization run (Run ID 1183-28782A) performed by STERIS at its Whippany, NJ facility between March 31 and April 1 of 2026.

Which lots are affected?

UDI 00607567700406, Serial/Lot Number 3000547797

Where was it sold?

US Nationwide distribution in the states of NY, CA, SC, FL, TX, GA, OR.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Maquet Cardiovascular

All 252

Other Surgical Instruments recalls

All 3,809